Recombinant human DcR1 protein (His tag)
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant human DcR1 protein (His tag) is a Human Fragment protein, in the 1 to 235 aa range, expressed in HEK 293 cells, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, FuncS.
View Alternative Names
CD263, DCR1, LIT, TRAILR3, TRID, UNQ321/PRO366, TNFRSF10C, Tumor necrosis factor receptor superfamily member 10C, Antagonist decoy receptor for TRAIL/Apo-2L, Decoy TRAIL receptor without death domain, Decoy receptor 1, Lymphocyte inhibitor of TRAIL, TNF-related apoptosis-inducing ligand receptor 3, TRAIL receptor without an intracellular domain, DcR1, TRAIL receptor 3, TRAIL-R3
- FuncS
Supplier Data
Functional Studies - Recombinant human DcR1 protein (His tag) (AB276266)
Measured by its binding ability in a functional ELISA. Immobilized human TNFRSF10C at 10 μg/mL (100 μL/well) can bind biotinylated human TNFSF10, the EC50 of biotinylated human TNFSF10 is 0.1-0.7 μg/mL.
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant human DcR1 protein (His tag) (AB276266)
SDS-PAGE analysis of ab276266
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Specifications
Form
Lyophilized
General info
Function
Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.
Post-translational modifications
N-glycosylated and O-glycosylated.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
EMBO reports 23:e54133 PubMed35758160
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com